BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3573418)

  • 21. [In vitro effects of aminoglycosides and cephalosporins on rat kidney lysosomes].
    Morin JP; Fillastre JP; Vaillant R
    C R Seances Soc Biol Fil; 1977; 171(5):1088-93. PubMed ID: 146551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of dosage regimen on experimental tobramycin nephrotoxicity. A biochemical approach.
    Olier B; Viotte G; Morin JP; Fillastre JP
    Chemotherapy; 1983; 29(6):385-94. PubMed ID: 6653171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cephaloridine and the rat kidney lysosomes stability in vitro.
    Ngaha EO
    West Afr J Pharmacol Drug Res; 1979; 5(1):25-35. PubMed ID: 555127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by lithium and rubidium of gentamicin-induced release of N-acetyl-beta-D-glucosaminidase from perfused rat kidney.
    Dehpour AR; Ghafourifar P; Ahangari N
    Toxicology; 1996 Jun; 110(1-3):9-15. PubMed ID: 8658563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminoglycoside antibiotics inhibit lysosomal phospholipase A and C from rat liver in vitro.
    Hostetler KY; Hall LB
    Biochim Biophys Acta; 1982 Mar; 710(3):506-9. PubMed ID: 7074128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside nephrotoxicity and urinary excretion of N-acetyl-beta-D-glucosaminidase.
    Langhendries JP; Battisti O; Bertrand JM
    Biol Neonate; 1988; 53(4):253-9. PubMed ID: 3046671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro response of hepatic lysosomes to endogenous and exogenous cationic compounds.
    Powell JH; Reidenberg MM
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):346-9. PubMed ID: 6463045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephrotoxicity of aminoglycosides and cephalosporins. Value of examining the isoenzyme profile of N-acetyl-beta-D-glucosaminidase].
    Dupond JL; Gibey R; Iehl-Robert M; Mallet H; Leconte des Floris R; Henry JC
    Rev Med Interne; 1984 Nov; 5(4):321-7. PubMed ID: 6522881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition by lithium of neomycin-induced release of N-acetyl-beta-glucosaminidase in the rat heart.
    Dehpour AR; Samini M; Ghafourifar P; Kyani H
    Pharmacol Toxicol; 1995 Mar; 76(3):202-5. PubMed ID: 7617546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of gentamicin among subcellular fractions from rat renal cortex.
    Weinberg JM; Hunt D; Humes HD
    Biochem Pharmacol; 1985 May; 34(10):1779-87. PubMed ID: 4004893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of acid phosphatase from lysosomal membranes by cathepsin D.
    Tanaka Y; Himeno M; Kato K
    J Biochem; 1990 Aug; 108(2):287-91. PubMed ID: 2121727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of vancomycin nephrotoxicity by other antibiotics in rats].
    Itoh F; Sato K; Harauchi T; Hirata M; Mizushima Y
    Jpn J Antibiot; 1995 Mar; 48(3):380-8. PubMed ID: 7752451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes].
    Mozer JL; Gibey R; Dupond JL; Henry JC
    Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal handling of tobramycin in the isolated perfused rat kidney.
    Aiba T; Itoga Y; Shimizu H; Tanigawara Y; Hori R
    J Pharm Sci; 1994 May; 83(5):723-6. PubMed ID: 8071829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of loss of latency of lysosomal enzymes. Effects of incubation on the properties of lysosomal membranes.
    Ruth RC; Weglicki WB
    Biochem J; 1980 Jan; 186(1):243-56. PubMed ID: 7370012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.
    Hostetler KY; Hall LB
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1663-7. PubMed ID: 6951205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prophylactic effects of a combined use of a cephem antibiotic, latamoxef, and tobramycin on postoperative infection in obstetrics and gynecology].
    Chimura T; Sato S; Suzuki T; Ito K; Sumiyoshi Y; Kanasugi H; Nakakuki M; Abe Y; Banzai M
    Jpn J Antibiot; 1987 Jul; 40(7):1253-8. PubMed ID: 3682180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of experimental tobramycin nephrotoxicity by ticarcillin.
    English J; Gilbert DN; Kohlhepp S; Kohnen PW; Mayor G; Houghton DC; Bennett WM
    Antimicrob Agents Chemother; 1985 Jun; 27(6):897-902. PubMed ID: 4026263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies on the in vivo effect of cephaloridine on the stability of rat kidney lysosomes.
    Ngaha EO
    Biochem Pharmacol; 1982 May; 31(10):1843-7. PubMed ID: 7104015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.